Stay updated on IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial
Sign up to get notified when there's something new on the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page.

Latest updates to the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page
- Check4 days agoChange DetectedUpdates the page’s displayed software/version identifier from the previous revision to the current one.SummaryDifference0.1%

- Check11 days agoChange DetectedA new site revision v3.5.2 was added and the previous revision v3.5.0 was removed from the history.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check40 days agoChange DetectedAdded revision: v3.5.0 and removed revision: v3.4.3 from the record history.SummaryDifference0.1%

- Check54 days agoChange DetectedNew revision entry v3.4.3 added to the history and the v3.4.2 entry removed.SummaryDifference0.1%

- Check76 days agoChange DetectedThe page shows an addition of Revision: v3.4.2 and a removal of Revision: v3.4.1, which are administrative site updates that do not affect study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedThe version history now includes Revision: v3.4.1 as an addition and Revision: v3.4.0 as a deletion. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMP321 with Paclitaxel in Metastatic Breast Carcinoma Clinical Trial page.